13. Recombinant derivatives of botulinum neurotoxins: should derivatives with light chain inactivating mutations retain biological activity?. (January 2015) - Band, Philip; Vazquez-Cintron, Edwin; Beske, Philip; Angeles, Christopher; Syngkon, Aurelia; McNutt, Patrick; Ichtchenko, Konstantin